Pekin Hardy Strauss’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,325
| Closed | -$344K | – | 315 |
|
|
2022
Q2 | $344K | Sell |
6,325
-500
| -7% | -$27.2K | 0.05% | 228 |
|
|
2022
Q1 | $372K | Buy |
6,825
+120
| +2% | +$6.54K | 0.05% | 253 |
|
|
2021
Q4 | $370K | Buy |
6,705
+116
| +2% | +$6.4K | 0.05% | 247 |
|
|
2021
Q3 | $315K | Buy |
6,589
+432
| +7% | +$20.7K | 0.04% | 259 |
|
|
2021
Q2 | $306K | Buy |
6,157
+1,064
| +21% | +$52.9K | 0.04% | 254 |
|
|
2021
Q1 | $227K | Buy |
+5,093
| New | +$227K | 0.04% | 271 |
|
|
2020
Q3 | – | Sell |
-3,997
| Closed | -$204K | – | 240 |
|
|
2020
Q2 | $204K | Buy |
+3,997
| New | +$204K | 0.05% | 197 |
|
|
2020
Q1 | – | Sell |
-3,997
| Closed | -$235K | – | 209 |
|
|
2019
Q4 | $235K | Hold |
3,997
| – | – | 0.04% | 191 |
|
|
2019
Q3 | $213K | Buy |
+3,997
| New | +$213K | 0.04% | 180 |
|
|
2019
Q2 | – | Sell |
-4,089
| Closed | -$214K | – | 203 |
|
|
2019
Q1 | $214K | Buy |
+4,089
| New | +$214K | 0.02% | 179 |
|
|
2018
Q4 | – | Sell |
-4,289
| Closed | -$215K | – | 195 |
|
|
2018
Q3 | $215K | Sell |
4,289
-1,196
| -22% | -$60K | 0.04% | 177 |
|
|
2018
Q2 | $276K | Buy |
5,485
+52
| +1% | +$2.62K | 0.05% | 158 |
|
|
2018
Q1 | $265K | Hold |
5,433
| – | – | 0.05% | 161 |
|
|
2017
Q4 | $241K | Buy |
5,433
+1,020
| +23% | +$45.2K | 0.04% | 165 |
|
|
2017
Q3 | $224K | Hold |
4,413
| – | – | 0.04% | 161 |
|
|
2017
Q2 | $238K | Hold |
4,413
| – | – | 0.04% | 158 |
|
|
2017
Q1 | $233K | Buy |
4,413
+48
| +1% | +$2.53K | 0.05% | 156 |
|
|
2016
Q4 | $210K | Sell |
4,365
-32
| -0.7% | -$1.54K | 0.02% | 155 |
|
|
2016
Q3 | $237K | Sell |
4,397
-800
| -15% | -$43.1K | 0.04% | 139 |
|
|
2016
Q2 | $282K | Sell |
5,197
-600
| -10% | -$32.6K | 0.06% | 129 |
|
|
2016
Q1 | $294K | Buy |
+5,797
| New | +$294K | 0.07% | 124 |
|